The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of pazopanib plus interferon alfa as first-line therapy of advanced renal cell carcinoma: a Spanish Oncology Genitourinary Group (SOGUG) study.
 
Xavier Garcia del Muro
Consulting or Advisory Role - Bayer; Pfizer
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Miguel Angel Climent
Consulting or Advisory Role - Novartis
 
Jose Luis Perez-Gracia
Research Funding - GlaxoSmithKline
 
Begona Mellado
No Relationships to Disclose
 
JA Virizuela
No Relationships to Disclose
 
Daniel E. Castellano
No Relationships to Disclose
 
Iciar Garcia Carbonero
No Relationships to Disclose
 
Aranzazu Gonzalez del Alba
Consulting or Advisory Role - Astellas Pharma; Bayer; GlaxoSmithKline; Janssen Oncology; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; PFIZER
 
Carlos Alvarez Fernandez
No Relationships to Disclose
 
Nuria Mulet
No Relationships to Disclose
 
Ignacio Duran
No Relationships to Disclose